273 related articles for article (PubMed ID: 36773106)
1. Retinal pathological features and proteome signatures of Alzheimer's disease.
Koronyo Y; Rentsendorj A; Mirzaei N; Regis GC; Sheyn J; Shi H; Barron E; Cook-Wiens G; Rodriguez AR; Medeiros R; Paulo JA; Gupta VB; Kramerov AA; Ljubimov AV; Van Eyk JE; Graham SL; Gupta VK; Ringman JM; Hinton DR; Miller CA; Black KL; Cattaneo A; Meli G; Mirzaei M; Fuchs DT; Koronyo-Hamaoui M
Acta Neuropathol; 2023 Apr; 145(4):409-438. PubMed ID: 36773106
[TBL] [Abstract][Full Text] [Related]
2. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
Shi H; Koronyo Y; Rentsendorj A; Regis GC; Sheyn J; Fuchs DT; Kramerov AA; Ljubimov AV; Dumitrascu OM; Rodriguez AR; Barron E; Hinton DR; Black KL; Miller CA; Mirzaei N; Koronyo-Hamaoui M
Acta Neuropathol; 2020 May; 139(5):813-836. PubMed ID: 32043162
[TBL] [Abstract][Full Text] [Related]
3. Ocular indicators of Alzheimer's: exploring disease in the retina.
Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's Retinopathy: Seeing Disease in the Eyes.
Mirzaei N; Shi H; Oviatt M; Doustar J; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurosci; 2020; 14():921. PubMed ID: 33041751
[TBL] [Abstract][Full Text] [Related]
5. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
[TBL] [Abstract][Full Text] [Related]
6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
7. Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status.
Shi H; Mirzaei N; Koronyo Y; Davis MR; Robinson E; Braun GM; Jallow O; Rentsendorj A; Ramanujan VK; Fert-Bober J; Kramerov AA; Ljubimov AV; Schneider LS; Tourtellotte WG; Hawes D; Schneider JA; Black KL; Kayed R; Selenica MB; Lee DC; Fuchs DT; Koronyo-Hamaoui M
bioRxiv; 2024 Feb; ():. PubMed ID: 38405854
[TBL] [Abstract][Full Text] [Related]
8. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
[TBL] [Abstract][Full Text] [Related]
10. Neuro-Retina Might Reflect Alzheimer's Disease Stage.
Santangelo R; Huang SC; Bernasconi MP; Falautano M; Comi G; Magnani G; Leocani L
J Alzheimers Dis; 2020; 77(4):1455-1468. PubMed ID: 32925026
[TBL] [Abstract][Full Text] [Related]
11. Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.
Schultz N; Byman E; ; Wennström M
J Alzheimers Dis; 2020; 73(3):1201-1209. PubMed ID: 31884473
[TBL] [Abstract][Full Text] [Related]
12. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
[TBL] [Abstract][Full Text] [Related]
13. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
[TBL] [Abstract][Full Text] [Related]
14. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.
Koronyo-Hamaoui M; Koronyo Y; Ljubimov AV; Miller CA; Ko MK; Black KL; Schwartz M; Farkas DL
Neuroimage; 2011 Jan; 54 Suppl 1():S204-17. PubMed ID: 20550967
[TBL] [Abstract][Full Text] [Related]
15. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
16. Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
Triplett JC; Swomley AM; Cai J; Klein JB; Butterfield DA
J Alzheimers Dis; 2016; 49(1):45-62. PubMed ID: 26444780
[TBL] [Abstract][Full Text] [Related]
17. Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.
Cullen NC; Mälarstig AN; Stomrud E; Hansson O; Mattsson-Carlgren N
Sci Rep; 2021 Jan; 11(1):1965. PubMed ID: 33479445
[TBL] [Abstract][Full Text] [Related]
18. Retinal Amyloid Imaging for Screening Alzheimer's Disease.
Tadokoro K; Yamashita T; Kimura S; Nomura E; Ohta Y; Omote Y; Takemoto M; Hishikawa N; Morihara R; Morizane Y; Abe K
J Alzheimers Dis; 2021; 83(2):927-934. PubMed ID: 34366344
[TBL] [Abstract][Full Text] [Related]
19. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
[TBL] [Abstract][Full Text] [Related]
20. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
